iTeos Therapeutics is a unique opportunity to join a private, biology-driven and preclinical stage company, newly incorporated as a spin-off of the Ludwig Institute for Cancer Research and the de Duve Institute at the Université catholique de Louvain.
In 2012, iTeos Therapeutics has raised €9M to leverage tumor immunology expertise from the Ludwig Institute to focus on discovery and development of first-in-class small molecule drugs that stimulate the immune system's ability to detect and eliminate cancers. It will validate their therapeutic use in preclinical and clinical models to improve the efficacy of cancer treatments, with an initial focus on the improvement of therapeutic cancer vaccines.
The company will offer a stimulating challenge for talented scientists and drug developers
with a strong entrepreneurial spirit.
We are looking for:
The purpose of this position is to develop the company’s research efforts in small molecule immunomodulators discovery and development. The responsibilities will include assay development and implementation to enable the progression of new small molecule therapeutics toward clinical development. The position will also involve the study of immune system-tumor interaction by development of ex vivo and in vivo models and evaluation of the immunomodulators using these models.
Key Tasks & Responsibilities
Professional Skills & Experience
Personal Skills & Competencies
Primary Location: Gosselies, Belgium
iTeos Therapeutics offers competitive compensation salary and benefits commensurate with experience level, as well as an opportunity to work within modern and well-equipped facilities. Employment is compatible with a choice of lifestyles either in the surrounding, rural communities, or the cosmopolitan, European capital of Brussels within commuting distance.
Only selected candidates will be contacted.
Please send your resume and motivation letter to firstname.lastname@example.org